[Federal Register Volume 72, Number 131 (Tuesday, July 10, 2007)]
[Notices]
[Page 37534]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E7-13327]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP); Provider and Public Health Input for Vaccine 
Policy Decisions, Potential Extramural Project (PEP), 2007-R-04

    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the aforementioned meeting.

    Time and Date: 12 p.m.-1:30 p.m., July 18, 2007 (Closed).
    Place: Teleconference.
    Status: The meeting will be closed to the public in accordance 
with provisions set forth in Section 552b(c)(4) and (6), Title 5 
U.S.C., and the Determination of the Director, Management Analysis 
and Services Office, CDC, pursuant to Public Law 92-463.
    Matters To Be Discussed: The meeting will include the review, 
discussion, and evaluation of applications received in response to 
PEP 2007-R-04, ``Provider and Public Health Input for Vaccine Policy 
Decisions.''
    Due to programmatic issues that had to be resolved, the Federal 
Register notice is being published less than fifteen days before the 
date of the meeting. This panel will reconvene to review 
applications that were not submitted for inclusion in the review 
process. The date for these panels had to be moved to a time when 
all panel members were available and with enough time to conduct 
secondary review and make appropriate funding decisions before the 
end of the fiscal year.
    For Further Information Contact:
    Christine J. Morrison, PhD, Scientific Review Administrator, 
Office of the Chief Science Officer, CDC, 1600 Clifton Road, NE., 
Mailstop D-72, Atlanta, GA 30333, Telephone (404) 639-3098.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both CDC and the Agency for Toxic Substances and 
Disease Registry.

Edward Schultz,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
[FR Doc. E7-13327 Filed 7-9-07; 8:45 am]
BILLING CODE 4163-18-P